Skip to content

Transperineal prostate biopsy without preoperative prophylactic antibiotics:A prospective randomized controlled study

Transperineal prostate biopsy without preoperative prophylactic antibiotics:A prospective randomized controlled study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200056775
Enrollment
Unknown
Registered
2022-02-16
Start date
2022-02-28
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate biopsy

Interventions

Experimental group:Transperineal prostate biopsy without prophylactic antibiotics
Control group:Transperineal prostate biopsy with prophylactic antibiotics

Sponsors

Guangdong Provincial Hospital of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age :45-80 years old (2) patients with indications of prostate biopsy according to Chinese Guidelines for diagnosis and Treatment of urological diseases (3) American Society of Anesthesiologists (ASA) grading 1-3; (4) Willingness to sign informed consent and adhere to the study protocol

Exclusion criteria

Exclusion criteria: (1) Patients with symptoms of urinary tract infection or WBC positive in urine test before biopsy; Or acute prostatitis in the past 6 months; Perineal skin infection (2) Patients with indwelling catheter (3) Patients with long time use of corticosteroids or immunosuppressive drugs (4) Patients with previously diagnosed prostate cancer (5) Non-urinary system bacterial infections that currently require active treatment with antibiotics (6) Patients with a history of allergy to the study drug (7) Severe cardiovascular and cerebrovascular diseases (8)There are contraindications for transperineal prostate puncture

Design outcomes

Primary

MeasureTime frame
Incidence of postoperative infectious complications;Incidence of sepsis;

Secondary

MeasureTime frame
Prostate cancer diagnosis rate;Incidence of urinary retention;Incidence of hematuria;Incidence of hematospermia;

Countries

China

Contacts

Public ContactPan Jun

Guangdong Provincial Hospital of Chinese Medicine

johnpcn@126.com13631369132

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026